Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.480NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.304NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.214.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.577NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.639NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19061.8South Korea
A.2.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.270NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.227NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
U.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.236NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.302NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.308NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.138NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.379NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.240NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.240.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.121.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
B.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.196NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.459NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used